麻豆传媒

Dr. Brent Goldfarb is an Associate Professor of Management and Entrepreneurship in the M&O Department at the University of Maryland's Robert H. Smith School of Business. Goldfarb's research focuses on how the production and exchange of technology differs from more traditional economic goods, with a focus on the implications on the role of startups in the economy. He focuses on such questions as how do markets and employer policies affect incentives to discover new commercially valuable technologies and when is it best to commercialize them through new technology-based firms? Why do radical technologies appear to be the domain of startups? And how big was the dot.com boom? Copies of Dr. Goldfarb's publications and working papers have been downloaded over 1200 times.

Andrew Maynard is a leading expert in the socially responsible development of emerging and converging technologies.

For over twenty years he has worked closely with experts and thought leaders from around the world on the challenges and opportunities presented by technologies ranging from nanotechnology and synthetic biology to geoengineering and artificial intelligence.

Maynard is a former physicist, a professor in the School for the Future of Innovation in Society. He directs of the ASU Risk Innovation Lab, and chairs the ASU Master of Science and Technology Policy program.

He writes the blog 2020 Science, and produces the YouTube channel Risk Bites. He is widely published in the academic literature, including in leading journals such as Nature, and is internationally recognized for his work on the risks and benefits of nanotechnology.

Leah Gerber researches marine conservation ecology, and environmental leadership and communication. Gerber’s research, teaching, and leadership advance the integration of science in decision processes to achieve sustainable biodiversity outcomes. As one of the world’s leading conservation scientists, Gerber frequently serves on globally significant bodies charting the future course of conservation. She is a professor in the School of Life Sciences and the founding director of the Center for Biodiversity Outcomes. Gerber is a recognized media source on global change and biodiversity and has been interviewed by The Economist, POLITICO, Time and other reputable media publications.

Sean Grant completed his doctorate in social intervention as a Clarendon Scholar at the Centre for Evidence-Based Intervention, University of Oxford. His scholarship aims to promote the use of scientific evidence to inform policymaking and programmatic decisions across various health and social sectors. As a research associate professor with the HEDCO Institute for Evidence-Based Educational Practice at the University of Oregon, Grant specializes in methods for synthesizing research evidence and expert opinion on 鈥渨hat works鈥� in addressing pressing societal issues. His work on these methods also involves collaborative, translational research focused on specific topics, such as substance use and mental health. 

I am a public affairs expert with a focus on advocating for sound science policy that supports
scientists and a thriving research community. I work closely with scientists to advocate
effectively and focus on engaging all stakeholders within the scientific community. I have
experience with public/private partnerships, regulatory policy, and global health policy. I earned
my Master's degree in biomedical science policy and a Bachelor's in international relations.

I bring more than 20 years of science policy experience to the Federation of American Societies for Experimental Biology (FASEB), a coalition of 23 scientific societies collectively representing more than 110,000 individual biological and biomedical researchers. I oversee the Federation's strategic investments in diversity, equity, accessibility, and inclusion and data sharing and reuse, while also guiding the overall strategic vision for FASEB’s science policy initiatives. My policy interests include scientific workforce development, open scholarship, and policy and regulatory oversight of research activities.
 I launched my policy career at the National Academies of Science, Engineering, and Medicine as a Christine Mirzayan Science and Technology Policy Fellow, where I worked on a report examining processes for identifying and appointing scientists to key federal advisory positions. After leaving the Academies, I held senior policy analyst positions at the research advocacy group FasterCures, the National Institutes of Health Office of Science Policy, and Thomson Reuters before joining FASEB in 2013. I hold a PhD in Genetics from Stony Brook University and received a BA in Zoology (Genetics Concentration) and Politics and Government from Ohio Wesleyan University.